Stockreport
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
Editas Medicine, Inc. (EDIT)
More Company Research
Source: GlobeNewswire
Last editas medicine, inc. earnings: 2/26 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF
Research includes the first-ever application of AsCas12a in vivo, optimized LNP delivery, and gene editing RNA guide modifications Data to support development of the Co
[Read more]
IMPACT SNAPSHOT
EVENT TIME:
{{FirstSection.LastPriceAtNewsEventTime2}}
EDIT
Last Price
{{SecondSection.LastPrice}}
Price Change
{{SecondSection.PriceChange}} {{SecondSection.PriceChangeTriangle_AMP}}
Price Change %
{{SecondSection.PriceChangePercent}} {{SecondSection.PriceChangeTriangle_AMP}}
Volume Shares
{{SecondSection.Volume}}
Max Up
{{SecondSection.MaxUp}}
Max Down
{{SecondSection.MaxDown}}
Volume Ratio
{{SecondSection.VolumeImpactStr_AMP}}%
{{SecondSection.PriceChangePercent}}
Don't Miss Out On The Next BIG Stock Move
{{GreenBoxData.Blurb}}
Performance comparison
Updated
{{SecondSection.VwapEventTime}}
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST PRICE AT
NEWS EVENT {{SecondSection.LastPriceAtNewsEvent}}
|
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
{{FirstSection.LastPrice}}
|
LAST PRICE |
{{SecondSection.LastPrice}}
|
{{FirstSection.VWapStr_AMP}}
{{FirstSection.VwapEventTime}}
|
VWAP |
{{SecondSection.VWapStr_AMP}}
{{SecondSection.VwapEventTime}}
|
{{FirstSection.MaxUp}}
High: {{FirstSection.EodHigh}}
|
MAX UP |
{{SecondSection.MaxUp}}
High: {{SecondSection.EodHigh}}
|
{{FirstSection.MaxDown}}
Low: {{FirstSection.EodLow}}
|
MAX DOWN |
{{SecondSection.MaxDown}}
Low: {{SecondSection.EodLow}}
|
{{FirstSection.TodaysRangeStr_AMP}}
{{FirstSection.RangEvg}}
|
POST NEWS RANGE |
{{SecondSection.TodaysRangeStr_AMP}}
{{SecondSection.RangEvg}}
|
{{FirstSection.PriceChange}}
{{FirstSection.PriceChangeTriangle_AMP}}
|
PRICE CHANGE |
{{SecondSection.PriceChange}}
{{SecondSection.PriceChangeTriangle_AMP}}
|
{{FirstSection.PriceChangePercent}}
|
PRICE CHANGE PERCENTAGE |
{{SecondSection.PriceChangePercent}}
|
{{FirstSection.Spx500}}
|
S&P 500 (SPX) |
{{SecondSection.Spx500}}
|
{{FirstSection.VolumeImpactStr_AMP}}
|
VOLUME RATIO |
{{SecondSection.VolumeImpactStr_AMP}}
|
{{FirstSection.Volume}}
|
VOLUME (SHARES) |
{{SecondSection.Volume}}
|
{{FirstSection.TicksString}}
|
TICKS |
{{SecondSection.TicksString}}
|
{{FirstSection.AvgTransactionSizeStr_AMP}}
|
AVG SHARES PER TRADE |
{{SecondSection.AvgTransactionSizeStr_AMP}}
|
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY